Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Journal of Chromatography|November 25, 1983
Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some of their metabolites by capillary gas chromatography combined with electron-capture and nitrogen-phosphorus selective detectionE A de Bruin, U R Tjaden, A T van Oosterom, et al.
Lancet (London, England)|July 30, 1983
Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemiaH P Sleeboom, O L Bijvoet, A T van Oosterom, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
Biological Mass Spectrometry|March 1, 1994
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometryG Momerency, K Van Cauwenberghe, P H Slee, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatmentJ W Elte, O L Bijvoet, F J Cleton, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1987
Magnetic resonance imaging of primary malignant bone tumorsJ L Bloem, R G Bluemm, A H Taminiau, et al.
Gynecologic Oncology|April 1, 1995
Primary extrauterine müllerian adenosarcoma of the peritoneumM J de Jonge, P A van Dam, E Van Marck, et al.
Amino Acids|November 19, 2004
Differential protein expression profile in gastrointestinal stromal tumorsB Landuyt, H Prenen, M Debiec-Rychter, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 6, 1999
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative GroupA Pawinski, S Tumolo, G Hoesel, et al.
British Journal of Cancer|August 1, 1995
Prognostic value of bcl-2 expression in invasive breast cancerP Hellemans, P A van Dam, J Weyler, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Journal of Chromatography|November 25, 1983
Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some of their metabolites by capillary gas chromatography combined with electron-capture and nitrogen-phosphorus selective detectionE A de Bruin, U R Tjaden, A T van Oosterom, et al.
Lancet (London, England)|July 30, 1983
Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemiaH P Sleeboom, O L Bijvoet, A T van Oosterom, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
Biological Mass Spectrometry|March 1, 1994
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometryG Momerency, K Van Cauwenberghe, P H Slee, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatmentJ W Elte, O L Bijvoet, F J Cleton, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1987
Magnetic resonance imaging of primary malignant bone tumorsJ L Bloem, R G Bluemm, A H Taminiau, et al.
Gynecologic Oncology|April 1, 1995
Primary extrauterine müllerian adenosarcoma of the peritoneumM J de Jonge, P A van Dam, E Van Marck, et al.
Amino Acids|November 19, 2004
Differential protein expression profile in gastrointestinal stromal tumorsB Landuyt, H Prenen, M Debiec-Rychter, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 6, 1999
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative GroupA Pawinski, S Tumolo, G Hoesel, et al.
British Journal of Cancer|August 1, 1995
Prognostic value of bcl-2 expression in invasive breast cancerP Hellemans, P A van Dam, J Weyler, et al.
Pageof 20